The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes. In recent years, the glucagon-like peptide-1 receptor agonist (GLP-1RA), a new type of hypoglycemic drug, has been shown to regulate blood sugar levels, improve myocardial ischemia, regulate lipid metabolism, improve endothelial function, and exert a protective role in the cardiovascular system. This study reviewed the protective effects of GLP-1RA on the cardiovascular system.
基金：
National Natural Science Foundation of China [81400288, 81573244]; Foundation of Health Commission of Hubei [WJ2021M061, WJ2019F071]; Natural Science Foundation of the Bureau of Science and Technology of Shiyan City [21Y71, 19Y89]; Hubei University of Medicine [2018QDJZR04]; Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine) [WDCM2020010]
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类|3 区医学
小类|3 区医学：研究与实验4 区内分泌学与代谢
最新[2025]版：
大类|3 区医学
小类|3 区内分泌学与代谢3 区医学：研究与实验
JCR分区：
出版当年[2020]版：
Q2ENDOCRINOLOGY & METABOLISMQ3MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版：
Q2ENDOCRINOLOGY & METABOLISMQ2MEDICINE, RESEARCH & EXPERIMENTAL
第一作者单位：[1]Hubei Univ Med, Sinopharm Dongfeng Gen Hosp, Shiyan 442000, Hubei, Peoples R China
通讯作者：
通讯机构：[1]Hubei Univ Med, Sinopharm Dongfeng Gen Hosp, Shiyan 442000, Hubei, Peoples R China[2]Hubei Univ Med, Sch Basic Med, Dept Immunol, Shiyan 442000, Hubei, Peoples R China[4]Hubei Univ Med, Hubei Key Lab Wudang Local Chinese Med Res, Shiyan, Peoples R China[5]Hubei Univ Med, Inst Virol, Shiyan 442000, Hubei, Peoples R China
推荐引用方式(GB/T 7714)：
Song Rui,Qian Hang,Wang Yunlian,et al.Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists[J].JOURNAL OF DIABETES RESEARCH.2022,2022:doi:10.1155/2022/4554996.
APA：
Song, Rui,Qian, Hang,Wang, Yunlian,Li, Qingmei,Li, Dongfeng...&Chen, Jun.(2022).Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists.JOURNAL OF DIABETES RESEARCH,2022,
MLA：
Song, Rui,et al."Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists".JOURNAL OF DIABETES RESEARCH 2022.(2022)
